The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of PBMC CD62Llow CD4+ T cells with irILD after nivolumab therapy.
 
Ou Yamaguchi
Consulting or Advisory Role - AstraZeneca Japan
Speakers' Bureau - AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Ono Pharmaceutical
 
Hiroshi Kagamu
Stock and Other Ownership Interests - Immunicon
Consulting or Advisory Role - AstraZeneca Japan; Immunicon
Speakers' Bureau - Bristol-Myers Squibb Japan; Ono Pharmaceutical
 
Fumikazu Sakai
Consulting or Advisory Role - AstraZeneca Japan; Boehringer Ingelheim; Ono Pharmaceutical
Speakers' Bureau - Boehringer Ingelheim
 
Atsuto Mouri
Speakers' Bureau - AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; Ono Pharmaceutical
 
Ayako Shiono
Speakers' Bureau - Ono Pharmaceutical
 
Harue Utsugi
No Relationships to Disclose
 
Fuyumi Nishihara
No Relationships to Disclose
 
Takahiro Uchida
Speakers' Bureau - AstraZeneca Japan
 
Yu Miura
No Relationships to Disclose
 
Kosuke Hashimoto
No Relationships to Disclose
 
Yoshitake Murayama
No Relationships to Disclose
 
Kunihiko Kobayashi
Consulting or Advisory Role - AstraZeneca Japan
Speakers' Bureau - AstraZeneca Japan; Chugai Pharma; Lilly; Ono Pharmaceutical